10:30 Harnessing Real-World Evidence to Support Early Development Pipelines & Key Inflection Points
Time: 10:30 am
day: Day 2 full
Details:
- Use RWE to identify key patient populations and treatment patterns early in development, guiding clinical trial design and optimizing recruitment strategies
- Leverage RWD to inform key inflection points in the development pipeline, such as dose selection, endpoint validation, and market entry timing
- Integrate RWE into decision-making processes to minimize risks, refine clinical strategies, and accelerate development timelines from early-stage to post-market phases
